{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:04:34Z","timestamp":1776434674306,"version":"3.51.2"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1053\/ajkd.2003.50141","type":"journal-article","created":{"date-parts":[[2003,2,28]],"date-time":"2003-02-28T17:48:30Z","timestamp":1046454510000},"page":"651-657","source":"Crossref","is-referenced-by-count":44,"title":["Chronic use of sodium ferric gluconate complex in hemodialysis patients: Safety of higher-dose (\u2265250 mg) administration"],"prefix":"10.1053","volume":"41","author":[{"given":"Vaughn W.","family":"Folkert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beckie","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel W.","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Myirski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Warnock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2003.50141_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","article-title":"Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial","volume":"316","author":"Eschbach","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2003.50141_bib2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-87-6-710","article-title":"Iron balance in hemodialysis patients","volume":"87","author":"Eschbach","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1053\/ajkd.2003.50141_bib3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0272-6386(05)80001-0","article-title":"Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis","volume":"37","author":"Fishbane","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50141_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0272-6386(97)90192-X","article-title":"Iron management in end-stage renal disease","volume":"29","author":"Fishbane","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50141_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0272-6386(99)70184-8","article-title":"Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial","volume":"33","author":"Nissenson","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50141_bib6","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/ki.1996.487","article-title":"A randomized controlled study of iron supplementation in patients treated with erythropoietin","volume":"50","author":"Macdougall","year":"1996","journal-title":"Kidney Int"},{"issue":"supp 1","key":"10.1053\/ajkd.2003.50141_bib7","first-page":"S182","article-title":"K\/DOQI Clinical Practice Guidelines for anemia of chronic renal disease, 2000","volume":"37","author":"National Kidney Foundation","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50141_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0272-6386(96)90546-6","article-title":"Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis","volume":"27","author":"Silverberg","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50141_bib9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1523-1755.2001.060002741.x","article-title":"Novel erythropoiesis stimulating protein for treatment of anemia in chronic renal insufficiency","volume":"60","author":"Locatelli","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50141_bib10","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69079.x","article-title":"Intravenous iron for the treatment of predialysis anemia","volume":"69","author":"Silverberg","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/ajkd.2003.50141_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1053\/ajkd.2000.17663","article-title":"Intravenous iron dextran treatment in predialysis patients with chronic renal failure","volume":"36","author":"Dahdah","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50141_bib12","series-title":"Ferrlecit\u00ae Prescribing Information","year":"2001"},{"key":"10.1053\/ajkd.2003.50141_bib13","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1046\/j.1523-1755.2002.00314.x","article-title":"Sodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextran","volume":"61","author":"Michael","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2003.50141_bib14","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69018.x","article-title":"Iron deficiency in patients with renal failure","volume":"69","author":"Nissenson","year":"1999","journal-title":"Kidney Int Suppl"},{"issue":"suppl 7","key":"10.1053\/ajkd.2003.50141_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/ndt\/16.suppl_7.9","article-title":"Individualizing target haemoglobin concentrations\u2014Tailoring treatment for renal anaemia","volume":"16","author":"Macdougall","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50141_bib16","first-page":"80","article-title":"Infusion of total dose iron versus oral iron supplementation in ambulatory peritoneal dialysis patients: A prospective, cross-over trial","volume":"16","author":"Ahsan","year":"2000","journal-title":"Adv Perit Dial"},{"key":"10.1053\/ajkd.2003.50141_bib17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0272-6386(99)70183-6","article-title":"Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans","volume":"33","author":"Faich","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50141_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0272-6386(01)80123-2","article-title":"Suspected iron dextran-related adverse drug events in hemodialysis patients","volume":"37","author":"Fletes","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50141_bib19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0272-6386(01)80137-2","article-title":"Should we still use iron dextran in hemodialysis patients?","volume":"37","author":"Horl","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50141_bib20","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/ndt\/16.6.1239","article-title":"A randomized controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs. iron gluconate (Ferrlecit) in hemodialysis patients treated with rHuEpo","volume":"16","author":"Kosch","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50141_bib21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/089686080102100310","article-title":"Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients","volume":"21","author":"Prakash","year":"2001","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2003.50141_bib22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ndt\/16.5.967","article-title":"A randomized study of oral vs. intravenous supplementation in patients with progressive renal insufficiency treated with erythropoietin","volume":"16","author":"Stoves","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50141_bib23","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/ajkd.2001.28587","article-title":"Intravenous iron sucrose: Establishing a safe dose","volume":"38","author":"Chandler","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50141_bib24","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/oxfordjournals.ndt.a027671","article-title":"Safety of intravenous injection of iron saccharate in haemodialysis patients","volume":"11","author":"Sunder-Plassmann","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50141_bib25","first-page":"183","article-title":"\u201cHigh dose\u201d sodium ferric gluconate (Ferrlecit) is safe and effective in peritoneal dialysis patients","volume":"29","author":"Javier","year":"2002","journal-title":"Nephrol Nurs J"},{"key":"10.1053\/ajkd.2003.50141_bib26","first-page":"615","article-title":"Pharmacokinetics of iron(III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers","volume":"46","author":"Danielson","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1053\/ajkd.2003.50141_bib27","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/ndt\/15.11.1827","article-title":"Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration","volume":"15","author":"Parkkinen","year":"2000","journal-title":"Nephrol Dial Transplant"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602692480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602692480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T18:53:34Z","timestamp":1584471214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638602692480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0272638602692480"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2003.50141","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}